NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of ...

The billionaire family that owns Purdue Pharma, maker of the pain medication blamed for helping fuel the nation’s opioid crisis, has agreed to increase payments to settle long-running litigation ...

T he Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...